Финансовые показатели
- Market Capitalization 50.64 B
- Employee 1 863
- Founded 2008
- CEO N/A
- Website www.argenx.com
- Headquarter Netherlands
- FIGI BBG00GHB88X9
- Industry Биотехнологии
Общий доход
Чистая прибыль
Общий долг
Свободный денежный поток
Денежные средства и эквиваленты
Связнные тикеры
| # | Название | Цена | 24ч % | 7д % | 1М % | 1Г % | Капитализация | Последние 7 дней | |
|---|---|---|---|---|---|---|---|---|---|
| 180 | MRNA Moderna, Inc. - Common Stock | 226.30 USD | +4.65% | +15.21% | +55.63% | +711.40% | 90.35 B USD | ||
| 206 | REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 778.36 USD | +3.35% | +4.88% | +0.33% | +33.51% | 80.14 B USD | ||
| 358 | RVMD Revolution Medicines, Inc. - Common Stock | 193.52 USD | +2.70% | -2.51% | -5.66% | +249.31% | 41.48 B USD | ||
| 444 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 224.47 USD | +0.29% | +1.09% | -6.28% | -52.72% | 30.04 B USD |